Abpro Holdings (ABPO) Other Non Operating Income (2024 - 2025)

Abpro Holdings' (ABPO) quarterly Other Non Operating Income came in at $200000.0 in Q2 2025, up 15.61% on a QoQ basis from $173000.0 in Q4 2024.

Abpro Holdings (ABPO) Other Non Operating Income (2024 - 2025) Analysis & Trends

Abpro Holdings (ABPO) has 2 years of Other Non Operating Income data on file, last reported at $200000.0 in Q2 2025.

Quarterly Other Non Operating Income changed N/A year-over-year to $200000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $373000.0 (down 90.0% YoY) and the FY2025 annual result came in at $200000.0, up 15.61% from the prior year.
Other Non Operating Income rose to $200000.0 in Q2 2025, from $173000.0 in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $3.6 million in Q1 2024 to a low of $173000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Abpro Holdings	1.14 Mn	1.14 Mn	-

Download Data